High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy-Reference-Cited by-同舟云学术

High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy

Published:2014-01 Issue:1 Volume:32 Page:47.e9-47.e14
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Raman Jay D.,Lin Yu-Kuan,Kaag Matthew,Atkinson Timothy,Crispen Paul,Wille Mark,Smith Norm,Hockenberry Mark,Guzzo Thomas,Peyronnet Benoit,Bensalah Karim,Simhan Jay,Kutikov Alexander,Cha Eugene,Herman Michael,Scherr Douglas,Shariat Shahrokh F.,Boorjian Stephen A.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference29 articles.

1. Management of patients with upper urinary tract transitional cell carcinoma;Raman;Nat Clin Pract Urol,2007

2. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients;Hall;Urology,1998

3. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm?;Brown;BJU Int,2006

4. Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration;Margulis;Cancer,2009

5. Chemotherapy of urothelial tumors;Yagoda;Cancer,1987

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in the Perioperative Management and Outcomes of Patients With Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy at Memorial Sloan Kettering Cancer Center: Over 20 Years of Experience;Urology Practice;2024-03

2. Complete Pathologic Response With Pembrolizumab and Enfortumab Vedotin in Urothelial Carcinoma of the Upper Urinary Tract;Journal of Investigative Medicine High Impact Case Reports;2024-01

3. Prognostic Impact of the Modified 5-Item Frailty Index After Radical Nephroureterectomy in Patients With Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study;Clinical Genitourinary Cancer;2023-11

4. Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site;Anticancer Research;2023-11

5. Lymph Node Dissection in Upper Tract Urothelial Carcinoma: Current Status and Future Perspectives;Current Oncology Reports;2023-10-06